Health
Could Coronavirus Variants Boost Pfizer’s Vaccine Sales By 50%? – Motley Fool
Probably not in the way some might think.
Fifteen billion dollars: That’s how much Pfizer(NYSE:PFE)projected last month in its Q4 update that it will make this year from its COVID-19 vaccine, BNT162b2. Sure, the company splits profits equally with its partner, BioNTech(NASDAQ:BNTX), but we’re still talking about a lot of money.
The actual amount will almost surely be even higher. Since Pfizer’s update, the U.S. government has ordered another 100 million doses of BNT162b2. But could Pfizer’s revenue from the vaccine be 50% higher because…
-
Noosa News23 hours agoMan dies after stabbing in inner-city unit
-
General22 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News22 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General13 hours agoAlbo and Dutton do battle for the Port of Darwin